Itamar Medical
For patients prescribed the WatchPAT ONE device by healthcare professionals for sleep-related breathing disorder screening.
Known forWatchPAT
WatchPATFor patients prescribed the WatchPAT ONE device by healthcare professionals for sleep-related breathing disorder screening.
WatchPATFacilitating home-based sleep apnea diagnostics through integrated hardware-software solutions for healthcare providers and their patients.
Target audience
Portfolio
Free 1Last updated
WatchPAT
v4.2.0
8mo ago
Primary focus
Medical diagnostic hardware integration
Scale
indie
Target audience
Patients prescribed the WatchPAT ONE device by healthcare professionals for sleep-related breathing disorder screening.
Maintained a consistent presence with 1 update to their single flagship diagnostic tool within the last six months.
1 app analysed
CloudPAT platform centralizes clinical workflows to increase switching costs
Single-market publisher — every app ships only to United States.
Based on 1 of 1 app with localized market data · last scanned .
0
Positive apps
1
Neutral / mixed
0
Negative apps
50/100
Avg sentiment score
NightOwl is the direct clinical-grade competitor, offering a home-based sleep apnea diagnostic solution that mirrors WatchPAT's core value proposition.
Strategic outlook coming soon.
What fed this analysis
Kardia sets the standard for medical-grade remote monitoring, representing the gold standard for clinical-to-consumer diagnostic apps.
Resmed dominates the CPAP therapy market, making myAir the primary destination for patients already diagnosed with sleep apnea.
Oura represents the high-end wearable market that is increasingly encroaching on medical sleep diagnostic territory.
While not a diagnostic tool, it serves the same user intent of identifying snoring patterns and sleep quality issues.
Welltory competes for the user's attention by providing broad health insights based on heart rate variability and sleep data.
